Clinical Trial

Using Tele-rehabilitation on Management of Pediatric Nocturnal Enuresis

Study acronym: UTMPNE
Completed
View on ClinicalTrials.gov →
Summary
Objective: To evaluate the effectiveness of telerehabilitation (via lifestyle and dietary advice) in managing primary nocturnal enuresis (bedwetting) in children aged 5-10 years. Background: Nocturnal enuresis is common in children and can be influenced by genetic, hormonal, and bladder-related factors. Treatment includes behavioral, pharmacological, and psychological approaches. Telerehabilitation-remote delivery of care-emerged during the COVID-19 pandemic as a promising tool for maintaining continuity of care. Methodology: Design: Randomized Controlled Trial Participants: Children aged 5-10 with primary NE (wetting ≥4 nights/week), recruited online. Exclusion: Children with secondary NE due to medical conditions or those on medication. Groups: Study group: Received telerehabilitation (lifestyle + dietary guidance). Control group: No telerehabilitation. Duration: 3 weeks (1 week baseline, 1 week intervention, 1 week follow-up) Assessment: Number of wet nights per week (using ICCS classification: responders, partial responders, non-responders) Pediatric quality of life Intervention Details: Telerehabilitation involved dietary recommendations (e.g., reducing evening fluid intake, avoiding caffeine/chocolate), lifestyle tips, and motivational counseling delivered remotely to caregivers. Data Analysis: Pre- and post-intervention outcomes compared using paired t-tests. Demographics and clinical characteristics recorded.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-30; most recent amendment 2026-04-06.
Status change: Active, Not Recruiting → Completed 2026-04-06
Trial Details
NCT Number NCT07108062
Lead Sponsor Hungarian University of Sports Science
Collaborators: Kafrelsheikh University
Conditions Enuresis Nocturnal, Urinary Incontinence
Enrollment 69 participants
Start Date 2025-06-29
Primary Completion 2026-01-29 (estimated)
Study Completion 2026-01-29 (estimated)
Updated on ClinicalTrials.gov 2026-04-07